Introduction
Neutrophils are the most numerous leukocytes, circulating in the bloodstream until called into the peripheral tissues due to local injury and/or infection. Upon extravasation from blood vessels and chemotaxis towards a site of injury or infection, neutrophils become progressively activated and undergo a startling transition that enables these cells to exert powerful antimicrobial effects [1, 2] . Activated neutrophils are highly phagocytic and can also release a panoply of soluble factors such as reactive oxygen species as well as a range of proteases and other degradative enzymes contained within their specialised granules [3] .
In addition to their antimicrobial roles, evidence also suggests that neutrophils play a major role in amplifying inflammatory responses [4] . Activated neutrophils are known to be capable of releasing multiple cytokines and chemokines and indeed, may be central to eliciting the migration of peripheral blood monocytes/macrophages into inflamed sites [5, 6] . Furthermore, soluble neutrophil-derived granule proteases have also been implicated in the processing and activation of members of the extended interleukin (IL)-1 cytokine family (IL-1a, IL-33, IL-36a, IL-36b and IL-36c) that have been released through tissue damage [7] [8] [9] [10] [11] . Thus, upon degranulation of activated neutrophils, extracellular elastase and cathepsin G (Cat G) have been implicated in the processing and activation of IL-1a, IL-33, and all three IL-36 cytokines [7] [8] [9] [10] .
Studies over the past 10 years have also demonstrated that activated neutrophils can undergo an unusual form of cell death, termed NETosis, which culminates in the expulsion of chromatin and other neutrophil constituents into the extracellular space [12] . Recent studies have also suggested that viable neutrophils can also form neutrophil extracellular traps (NETs) in a nonlytic manner, through expulsion of mitochondrial DNA, and retain phagocytic and crawling capabilities in a process termed 'vital NETosis' [13, 14] . While the precise mechanism of this mode of cell death remains under investigation, it appears that NETosis may facilitate entrapment of bacteria, yeast and other microorganisms in a mesh-like structure that consists of DNA, histones, antimicrobial proteins and neutrophil granule proteases such as elastase and Cat G [12, 15, 16] . Indeed, after histones, elastase has been found to be the most abundant protein constituent of NETs, although a specific role for this protease, or indeed other NET-associated proteases, has not been demonstrated in this context [12, 17] . High concentrations of NETs have been detected in a range of autoinflammatory and autoimmune diseases including systemic lupus erythematosus (SLE), cystic fibrosis, necrotising vasculitis and psoriasis, and have been implicated in potentiating inflammation in these settings [18, 19] . Thus, we wondered whether NETassociated proteases were capable of processing and activating extracellular cytokines, potentially explaining the proinflammatory effects of these structures.
Here, we show that neutrophil NETs are decorated with neutrophil granule proteases Cat G, elastase and proteinase-3 (PR-3). NET-associated proteases, particularly Cat G, robustly processed and activated IL-36a, IL-36b and IL-36c as well as IL-1a, thereby unleashing the biological activity of these cytokines. Thus, in addition to their microbial trapping functions, NETs may also act as local platforms for IL-1 family cytokine activation, serving to escalate inflammation through processing of the latter cytokines upon release via tissue damage.
Results

Neutrophil extracellular traps contain granule serine proteases
Upon activation, neutrophils undergo an oxidative burst that leads to release of their granule contents into the extracellular space, followed by the production of extracellular traps. Previous reports have suggested that neutrophil NETs contain several proteases such as elastase and Cat G [17] . However, the role that the latter proteases play in this context is unclear, as much of the antimicrobial activity of NETs has been ascribed to histones and other NET constituents, such as DNA and calprotectin, rather than to NET-associated proteases [12, 17, 20] .
We initially set out to confirm that neutrophil granule proteases were indeed associated with NETs. Neutrophils were activated with phorbol 12-myristate 13-acetate (PMA) for 4 h to induce degranulation and release of granule proteases into cell supernatants, as well as NET formation, as described previously [21] . As expected, neutrophils stimulated with PMA released soluble Cat G into the medium, as indicated by Phe-Leu-Phe-thiobenzyl ester (FLF-sBzL) hydrolysis, as well as elastase and PR-3, as indicated by AlaAla-Pro-Val-7-amido-4-methylcouramin (AAPV-AMC) hydrolysis (Fig. 1A,B) . We also analysed neutrophil cell-associated and supernatant-associated proteases by immunoblot analysis, before and after activation with PMA. As expected, neutrophils released Cat G, elastase and PR-3 into the extracellular space in response to PMA, whereas these proteins could not be detected in untreated neutrophil supernatants (Fig. 1C) . However, activated neutrophils also retained some Cat G, elastase and PR-3 in the cellular fraction, suggesting that proteases also remain cell bound, possibly associated on NET structures. As previously reported, PMA-treated neutrophils also generated NET structures, as indicated by diffuse/spread chromatin staining, which frequently extended well beyond the cell body ( Figs 1D and 2 ).
NET-associated proteases are accessible to the extracellular space
As previous studies have demonstrated that neutrophil granule proteases are components of NETs [17, 22] , we explored the surface accessibility of the latter proteases on NETs using immunostaining. Thus, untreated versus PMA-treated neutrophils were stained with specific antibodies against Cat G, elastase or PR-3, in combination with Hoechst staining to visualise NET structures. Importantly, neutrophils were not permeabilised before staining, thus specific staining represents proteases accessible to the extracellular space. As shown in Fig. 2 , activated neutrophils generated NETs that were surface decorated with Cat G, elastase and PR-3. In contrast, neutrophils that had not undergone NETosis failed to externalise any of these proteases (Fig. 2) . Thus, as previous proteomic analyses have indicated [17] , neutrophil NETs contain multiple proteases that are accessible to extracellular substrates.
NET-associated protease activity can activate IL-36 cytokines
Accumulating evidence has implicated IL-36 family cytokines as key inflammatory mediators in a variety of inflammatory disorders, particularly psoriasis, which is also associated with extensive neutrophil influx [23, 24] . IL-36 cytokines are completely inactive as full-length proteins and require N-terminal processing to unleash their proinflammatory activity [10, 25, 26] . We have recently found that neutrophilderived proteases differentially process and activate IL-36a, IL-36b and IL-36c [10] . In agreement with this, incubation of all three IL-36 cytokines with activated neutrophil supernatants resulted in robust activation of these proteins (Fig. 3) . Thus, soluble neutrophil proteases released during degranulation can potently activate IL-36 cytokines. However, the role of NET-bound proteases in the modulation of cytokine activity has not been investigated and indeed, some reports suggest that NET-associated neutrophil proteases may be inactive [27] . per well) were stimulated, or not, with 100 nM PMA for 4 h, 37°C. NET formation was assessed and counted by confocal microscopy. Fig. 2 . NET-associated proteases are exposed to the extracellular space. Neutrophils were stimulated, or not, with 100 nM PMA for 4 h, 37°C followed by washing of plate-bound cells/NETs three times with PBS (2 mL) to remove soluble proteases. Cells/NETs were immunostained with Hoechst to visualise DNA (blue), or with specific antibodies against Cat G, elastase or PR-3 (green) and visualised by confocal microscopy. Note: cells were not permeabilised prior to immunostaining. 
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Neutrophil-derived extracellular traps constitute a source of neutrophil proteases bound to long chromatin fibres that may be more concentrated than proteases released during degranulation, due to dispersal of the latter into the extracellular space. To explore whether NET-associated proteases could also act as platforms for cytokine activation, neutrophil NETs were washed extensively to remove soluble proteases released during degranulation, leaving only NETbound protease activity (Fig. 4A) . Washed NETs were then incubated with inactive full-length IL-36 cytokines, followed by assessment of IL-36 bioactivity by addition to IL-36-responsive HeLa cells (Fig. 4A ). To ensure that activation of IL-36 cytokines could be specifically attributed to NET-bound protease activity, and not activity from residual soluble proteases that were liberated from NETs during the incubation process, we measured soluble and cell-associated protease activity for 1 h after washing NETs. While supernatants from activated neutrophils contained potent elastase activity (Fig. 4B ), no soluble protease activity was detected even up to 1 h after washing NETs (Fig. 4B ). However, elastase activity was readily detected associated with the plate-bound neutrophil/ NET population (Fig. 4C) . Thus, neutrophil NETs do appear to contain active proteases accessible to extracellular substrates.
Furthermore, while untreated neutrophils had no effect on the activity of full-length IL-36a added to these cells, incubation of washed NETs with IL-36a robustly enhanced the activity of this cytokine (Fig. 5A) . Similar results were seen upon addition of IL-36b and IL-36c to NET preparations (Fig. 5A) , both of which were also activated through coincubation with NETs. To rule out the possibility that small amounts of soluble proteases (that remained after washing NETs) mediated the activation of IL-36 cytokines in this context, we also assessed the ability of supernatant from washed NETs to process and activate IL-36b. While incubation of IL36b with NETs robustly activated this cytokine as before, the supernatants taken postwashing failed to activate IL-36b suggesting that that the cytokine processing activity was indeed NET-bound (Fig. 5B) . Thus, NETs contain protease activity capable of processing and activating IL-36 cytokines present in the extracellular space.
NET-mediated activation of IL-36 cytokines is mediated by cathepsin G and elastase
Although NETs contain detectable Cat G, elastase and PR-3 ( Fig. 2) , it was formally possible that other proteases could be responsible for the cytokine processing observed (Fig. 5) . We have previously identified the protease cleavage sites in IL-36b and IL-36c that are targeted by Cat G and elastase respectively (Henry et al., 2016; Fig. 6A ). Point mutations at these sites eliminate IL-36 activation by the latter proteases [10] . To investigate the contribution of Cat G in the activation of IL-36b by NETs, we treated NETs with either wild-type IL-36b, or an IL-36b R5A point mutant that resists processing and activation by Cat G. As shown in Fig. 6B , whereas wild-type IL-36b was robustly activated by NETs, as before, NETs failed to activate the IL-36b R5A mutant, suggesting that NETassociated Cat G was responsible for activation of IL36b (Fig. 6B) . Using a similar approach, IL-36c V15G , which resists activation by elastase and PR-3 [10] , also resisted activation by NETs (Fig. 6B) . Collectively, these data suggest that Cat G and elastase associated per mL) were stimulated with PMA (100 nM) for 4 h, 37°C. After 4 h, neutrophil supernatants were harvested and elastase activity in the supernatants was measured by AAPV-AMC hydrolysis assay. The remaining plate-bound cells/NETs were washed three times with PBS (2 mL) to remove soluble proteases, followed by incubation with fresh HBSS/0.25% BSA for 1 h. Supernatants from washed neutrophils/ NETs were then re-assayed 1 h after washing and elastase activity was measured by AAPV-AMC hydrolysis assay. (C) Neutrophils/NETs were treated as in (B), washed and incubated with AAPV-AMC (50 lM) to measure cell-associated elastase enzymatic activity. Samples were taken at indicated timepoints after addition of AAPV-AMC.
with NETs selectively process and activate IL-36 cytokines to enhance their bioactivity.
Inhibition of NET-associated proteases block IL-36 cytokine activation
To further confirm that NET-bound Cat G and elastase processed and activated IL-36 cytokines, we used chemical inhibitors of the latter proteases to inhibit their enzymatic activity. NETs were either left untreated, or were treated with Cat G or elastase inhibitors, or a combination of both, for 30 min to block protease activity, followed by addition of IL-36 cytokines. As shown in Fig. 7 , whereas inhibition of Cat G activity potently suppressed NET-associated activation of IL-36a and IL-36b, inhibition of elastase had little effect on NET-mediated activation of these cytokines. This is in good agreement with previously published results that Cat G is the primary mediator of IL-36a and IL-36b activation [10] . Conversely, inhibition of elastase, as well as Cat G, attenuated IL-36c activation by NETs (Fig. 7) . The contribution of Cat G to IL36c activation was somewhat surprising here, as we previously implicated elastase as the main activator of IL-36c. However, Drag and colleagues have recently shown that much of the NET-bound elastase is inactive [27] , which may result in Cat G playing a more prominent role here.
DNase I treatment attenuates IL-36b activation by NETs
Neutrophil extracellular traps can be dismantled by targeting the DNA backbone of these structures using DNase I [12, 13, 28] . Indeed, it has been suggested that expression of DNases by bacteria promotes the degradation of NETs and facilitates bacterial escape and dissemination [29, 30] . To confirm further that NETbound proteases specifically mediate the activation of IL-36 cytokines, we pretreated washed NETs with DNase I to promote their degradation, followed by assessment of IL-36 processing activity. As can be seen in Fig. 8 , treatment with DNase I lead to a reduction in long NET structures externalising elastase (Fig. 8A) . While activated neutrophils/NETs robustly activated IL-36b as before, pretreatment of NETs with DNase I potently attenuated subsequent IL-36b activation by these structures (Fig. 8C) . These results confirm that extracellular NET-bound proteases can process and activate extracellular cytokines.
NET-associated proteases can activate IL-1a
Because multiple IL-1 family members are known to be processed and activated by neutrophil-derived proteases [7, 9, 11] , we also investigated whether other members of the IL-1 cytokine family can be activated by NETs. Similar to IL-36 family cytokines, IL-1a is released during necrotic cell death and functions as an alarmin to promote inflammation [11, 31, 32] . Unlike IL-36 family cytokines, IL-1a is active in its full-length form but this activity can be enhanced 8-10-fold through processing by neutrophil proteases [7, 9] . Consistent with this, IL-1a activity was robustly enhanced upon incubation with washed NETs (Fig. 9) . Collectively, the preceding observations argue that, in addition to their antimicrobial roles, neutrophil NETs can also directly regulate inflammation by modulating the activation of extracellular cytokines released through injury. 
Discussion
Here, we have shown that neutrophil NET-bound proteases possess enzymatic activity and can process and activate IL-36a, IL-36b and IL-36c, as well as IL-1a, to enhance their proinflammatory potential. Thus, NETs may serve diverse functional roles in the context of infection as well as sterile injury, through entrapping microorganisms, and also by serving as platforms for processing of extracellular cytokines liberated via tissue necrosis. In the latter role, NETs may amplify inflammatory responses, which might be detrimental in settings where excessive NET formation occurs. Neutrophils undergo NETosis in response to a variety of activating stimuli including PMA, IL-8 and lipopolysaccharide (LPS) [12] . Although NETs most likely function to limit bacterial infection and sequester microbes extracellularly, recent studies have also implicated NETs as mediators of inflammation and disease. It has been suggested that excessive NET formation, or defective NET clearance, can contribute to inflammation and tissue damage and promote autoimmunity by externalising autoantigens [18, [33] [34] [35] [36] . Consistent with this, NETs have been implicated in the pathogenesis of a number of inflammatory and autoimmune diseases including rheumatoid arthritis, cystic fibrosis, SLE and psoriasis [19, 37] .
Immune cell infiltration is a hallmark of a number of skin-related inflammatory diseases. In particular, psoriatic plaques are heavily infiltrated with neutrophils, dendritic cells, macrophages, as well as Tcells, and key roles for a number of proinflammatory cytokines, including IL-36, IL-17, IL-22 and tumour necrosis factor a (TNFa), have been identified in this condition [38] [39] [40] [41] [42] . Accumulating evidence implicates neutrophil serine proteases as proinflammatory mediators by regulating the activity of extracellular cytokines and chemokines including IL-8, TNFa and IL-1 family cytokines via proteolytic processing [4, 9, 43, 44] . The modulation of cytokine activity by NET-bound granule proteases may play a role in inflammatory contexts associated with excessive neutrophil recruitment. All three IL-36 cytokines have been detected in psoriatic lesional skin and these cytokines appear to be key mediators of the pathogenesis of psoriasis [41] . NETs have also been detected in psoriatic lesions and detection of these structures is correlated with disease severity [45] . Thus, it is possible that NET-mediated activation of IL-36 cytokines may play a role in psoriatic inflammation.
In conclusion, along with their capacity to impede microbial dissemination and infection, we have shown that NETs can escalate inflammation through processing of proinflammatory cytokines. Thus, NET-bound 
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Elastase inhibitor CatG+Elastase inhibitor serine proteases are active and can regulate extracellular IL-1 family cytokine activity, through processing and unleashing the biological activity of these important alarmins.
Experimental procedures
Materials
Synthetic peptides, Suc-FLF-SBzl and Suc(oMe)-AAPV-AMC, were purchased from Bachem (Weil am Rein, Germany). Anti-Cat G antibody was purchased from Santa Cruz and anti-PR-3 antibody (clone 4A5) was purchased from Weislab. Anti-elastase antibody was a kind gift from Prof. Arturo Zychlinsky. Anti-histone H3 was from Abcam and anti-actin was from MB Biomedicals (Santa Ana, CA, USA). Chemical inhibitors cathepsin-G inhibitor I (219415) and elastase inhibitor IV (324759) were purchased from Calbiochem (Nottingham, UK). DNase I (Type IV, from bovine pancreas) was purchased from Sigma Ltd. (Arklow, Ireland). Unless otherwise indicated, all other reagents were purchased from Sigma Ltd.
Cell culture
HeLa cells were cultured in Roswell Park Memorial Institute medium (RPMI) media (Gibco, Waltham, MA, USA), supplemented with 5% fetal bovine serum (FBS). HeLa cell line was generated by transfection with pCXN2.IL1Rrp2 (IL-36R) plasmid followed by selection using G418 antibiotic (Sigma). IL-36R overexpressing clones were expanded from single cells using limiting dilution cloning followed by expansion of individual clones. All cells were cultured at 37°C in a humidified atmosphere with 5% CO 2 .
Expression and purification of recombinant IL-36
Full-length IL-36a, b and c proteins were generated by cloning the human coding sequence in frame with the polyhistidine tag sequence in the bacterial expression vector pET45b. Protein was expressed by addition of 600 lM isopropyl b-D-1-thiogalactopyranoside (IPTG) to exponentially growing cultures of ClearColi strain Escherichia coli followed by incubation for 3 h at 37°C. Bacteria were lysed by sonication and polyhistidine tagged proteins were captured using nickel-nitrilotriacetic acid agarose (Amintra, Expedeon Ltd, Cambridgeshire, UK), followed by elution into phosphate-buffered saline (PBS), pH 7.2, in the presence of 100 mM imidazole. IL-1a was expressed as previously described [7] . All recombinant cytokines used in these assays were expressed and purified using ClearColi to eliminate endotoxin contamination of protein preparations which may interfere with these assays as neutrophils are highly sensitive to LPS stimulation.
Isolation of neutrophils
Primary neutrophils were purified from peripheral human blood using discontinuous plasma-Percoll gradients as described previously [46] . Briefly, peripheral blood from healthy volunteers was collected in lithium heparinised tubes (Greiner, Kremsmunster, Austria). Blood was pooled in 50 mL tubes containing 4.4 mL of 5% sodium citrate. Blood was centrifuged at 300 g for 20 min. The platelet-rich plasma was removed and centrifuged at 2500 g for 15 min to obtain platelet-poor plasma (PPP). To the remaining blood, 5 mL of 6% dextran (mol. wt. 500 000, Sigma) was added and volume was topped up to 50 mL with 0.9% saline solution, mixed gently and stood for 30-40 min to allow erythrocyte sedimentation to occur. During dextran sedimentation, a stock solution of Percoll (Sigma) was prepared in 0.9% saline in a ratio of 9 : 1 (vol/vol) Percoll/saline. After 30-40 min, the leucocyte-rich plasma was aspirated and centrifuged at 280 g for 6 min. The resulting pellet was resuspended in 3 mL PPP and transferred to 13 mL sterile tube containing 2 mL freshly prepared 42% Percoll in PPP underlayed with 2 mL 51% Percoll in PPP. The gradients were centrifuged for 10 min at 280 g. Neutrophils are found at the interface between the 42% and 51% gradients and extend into the 51% gradient to just above the erythrocyte pellet. The neutrophil fraction was washed twice in Hank's balanced salt solution (HBSS)/0.25% bovine serum albumin (BSA; without calcium or magnesium) and pelleted at 250 g for 5 min. After washing, neutrophils were resuspended in HBSS/ 0.25% BSA with calcium and magnesium and plated for assays. Purity of cell populations was determined by haematoxylin and eosin staining of cytospins.
Activation of neutrophils with PMA
To prepare neutrophil degranulate supernatant, cells (1 9 10 7 cells per mL) were stimulated, or not with 100 nM PMA in HBSS/0.25% BSA for 2 h at 37°C in a humidified atmosphere with 5% CO 2 . Supernatants were harvested and clarified by centrifugation. Neutrophil degranulate supernatant was stored at À80°C. To induce NET formation, neutrophils (5 9 10 6 -1 9 10 7 cells per mL) were stimulated, or not with 100 nM PMA in HBSS/0.25% BSA for 4 h at 37°C.
Cytokine activation by neutrophil extracellular traps
Neutrophils (1 9 10 7 cells per well) were stimulated, or not with 100 nM PMA in HBSS/0.25% BSA for 4 h at 37°C. 
Fluorimetric analysis of neutrophil protease enzymatic activity
Reactions were carried out in protease reaction buffer (PRB; 50 mM HEPES, pH 7.4, 75 mM NaCl, 0.1% CHAPS, 2 mM DTT) containing Suc(oMe)-AAPV-AMC to measure elastase activity. Samples were measured using an automated fluorimeter (SparkM, TECAN, Reading, UK) at wavelengths of 360 nm (excitation) and 465 nm (emission). For suc-FLFsBzL assay to measure cathepsin-G activity, substrate was diluted to a final concentration of 300 lM in PRB [50 mM HEPES, pH 7.4, 75 mM NaCl, 0.1% CHAPS, 300 lM 5,5 0 -dithiobis(2-nitrobenzoic acid) (DTNB)]. Samples were measured using an automated fluorimeter (SparkM, TECAN) at an absorbance wavelength of 430 nm.
Neutrophil extracellular trap immunostaining
Neutrophils (2 9 10 6 or 5 9 10 6 cells per well) were plated on coverslips coated with 0.001% poly-L-lysine (Sigma) and treated with 100 nM PMA in HBSS/0.25% for 2-4 h at 37°C. After 4 h, cell supernatant was removed and cells were washed three times with PBS (2 mL). Neutrophils were fixed with 4% paraformaldehyde for 15 min. Cells were blocked with 2% BSA (in PBS, pH 7.4) for 1 h to reduce nonspecific binding of antibodies. Specific primary antibodies were diluted in 2% BSA and typically used at 1 : 100-1 : 500 dilution. Primary antibodies were incubated for 2 h at room temperature. Cells were washed 3 times with 2 mL of PBS. Cells were incubated with relevant secondary antibody diluted 1 : 1000 in 2% BSA for 1 h at room temperature. Cells were washed again with PBS, followed by incubation with Hoechst (500 nM) for 10 min. Coverslips were mounted on slides with 5-10 lL of Slow Fade (Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA). Cells were visualised and analysed using a laser scanning confocal microscope (FV1000; Olympus, Center Valley, PA, USA) using a 488 nm Argon laser (green fluorescence) and a 405 nm LD laser (Hoechst). Confocal images were acquired as z stacks on FLUOVIEW 1000 V.1 software (Olympus, Center Valley, PA, USA).
Measurement of cytokines and chemokines
Cytokines and chemokines were measured from cell culture supernatants using specific ELISA kits obtained from R&D systems (human IL-6, IL-8). All cytokine assays were carried out using triplicate samples from each culture.
Western immunoblotting
Protein samples were prepared using SDS loading buffer, boiled for 7 min and electrophoresed on 12% SDS/PAGE gels. Proteins were then transferred onto 0.2 lM nitrocellulose membrane at 40 mA overnight. Membranes were blocked for 1 h (5% nonfat dry milk (NFDM), 0.05% sodium azide in Tris-buffered saline, Tween-20, TBST). The indicated proteins were probed using specific antibodies, typically diluted 1 : 1000. Membranes were washed three times in TBST and then incubated with the relevant HRP-conjugated secondary antibody (Jackson ImmunoResearch Labs, West Grove, PA, USA) diluted 1 : 2000. Membranes were again washed and proteins were visualised with SuperSignal West Pico (Thermo Scientific, Waltham, MA, USA) and exposure to autoradiography films.
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